ADVERTISEMENT
ADVERTISEMENT

Birth Control Pills and Prostate Cancer

A new study suggests a possible link between the use of oral contraceptives and rising prostate cancer rates.

Bob Grant
Bob Grant

Bob Grant is Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.

View full profile.


Learn about our editorial policies.

Ortho Tri-Cyclen oral contraceptivesWIKIMEDIA COMMONS, BETTEDAVISEYES

In some regions of the world, increased use of oral contraceptives may be associated with driving up rates of prostate cancer, according to a paper published this week in BMJ Open. Canadian researchers found a significant positive relationship between 2007 data on contraceptive use and global prostate cancer rates from the same year, with the strongest relationship showing up in Europe. No such relationship was found between prostate cancer and the use of other contraceptives, such as condoms and intrauterine devices.

The scientists suggested that hormones, especially estrogen, from the urine of people taking the pills may be leaching into the environment and contaminating drinking water or food supplies. Estrogen by-products are known to spur the growth of some tumors. But the Toronto University researchers, David Margel and Neil Fleshner, who authored the report, are quick to point out that their data...

Some experts are still more dubious of the results. "Comparing the rates of two apparently unrelated issues across countries is a notoriously unreliable way of establishing whether they are truly linked," Cancer Research UK spokesperson Jessica Harris told BBC News. "So many things vary between different countries that it's impossible to say whether one thing is causing the other."

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
ADVERTISEMENT